BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35768054)

  • 1. Neurotrophic Keratopathy in the United States: An Intelligent Research in Sight Registry Analysis.
    Bian Y; Ma KK; Hall NE; Elze T; Lorch A; Miller JW; Dana R; Yin J
    Ophthalmology; 2022 Nov; 129(11):1255-1262. PubMed ID: 35768054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual Acuity Outcomes and Complications after Intraocular Lens Exchange: An IRIS® Registry (Intelligent Research in Sight) Analysis.
    Son HS; Chang DF; Li C; Liu L; Zafar S; Lum F; Woreta FA
    Ophthalmology; 2024 Apr; 131(4):403-411. PubMed ID: 37858872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, prevalence, and outcome of moderate to severe neurotrophic keratopathy in a German tertiary referral center from 2013 to 2017.
    Roth M; Dierse S; Alder J; Holtmann C; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1961-1973. PubMed ID: 34989864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomes.
    Saad S; Abdelmassih Y; Saad R; Guindolet D; Khoury SE; Doan S; Cochereau I; Gabison EE
    Ocul Surf; 2020 Apr; 18(2):231-236. PubMed ID: 31759182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-Globe Injury Repairs in the American Academy of Ophthalmology IRIS® Registry 2014 - 2018: Incidence, Risk Factors, and Visual Outcomes.
    Tomaiuolo M; Woreta FA; Li A; Yonekawa Y; Zhang QE; Sharpe JE; Zafar S; Syed ZA; Ramesh S; Lorch AC; Hall NE; Shah AS; Justin GA; Hyman L;
    Ophthalmology; 2023 Aug; 130(8):812-821. PubMed ID: 36924850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in Visual Acuity Outcomes after Endothelial Keratoplasty: An Intelligent Research in Sight Registry Analysis.
    Srikumaran D; Son HS; Li C; Schein O; Pramanik S
    Ophthalmology; 2022 Aug; 129(8):912-922. PubMed ID: 35405178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and Outcomes of Patients with Scleritis in the IRIS® Registry (Intelligent Research in Sight) Database.
    Armbrust KR; Kopplin LJ
    Ophthalmol Sci; 2022 Sep; 2(3):100178. PubMed ID: 36245751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical characteristics of neurotrophic keratopathy in hispanic population in northeastern Mexico.
    Castillo-Macías A; Arreola-Martínez JE; Loya-García D; Valdez-García JE
    Int Ophthalmol; 2023 Sep; 43(9):3257-3262. PubMed ID: 37140835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of response to multimodal management of neurotrophic corneal disease.
    Trinh T; Santaella G; Mimouni M; Mednick Z; Cohen E; Sorkin N; Rootman DS; Slomovic AR; Chan CC
    Ocul Surf; 2021 Jan; 19():330-335. PubMed ID: 33189904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic keratopathy: current challenges and future prospects.
    NaPier E; Camacho M; McDevitt TF; Sweeney AR
    Ann Med; 2022 Dec; 54(1):666-673. PubMed ID: 35243932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology, Treatment Patterns, and Outcomes for Choroidal Neovascularization in the Pediatric Population: An Intelligent Research in Sight (IRIS®) Registry Study.
    Finn AP; Fujino D; Lum F; Rao P
    Ophthalmol Retina; 2022 Feb; 6(2):130-138. PubMed ID: 34091079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic keratopathy: An updated understanding.
    Neurotrophic Keratopathy Study Group
    Ocul Surf; 2023 Oct; 30():129-138. PubMed ID: 37666470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the ocular surface in neurotrophic keratitis induced by trigeminal nerve injury following neurosurgery.
    Xie C; Liu B; Zhao X; He Q; Liu L; Wei R
    Int Ophthalmol; 2023 Apr; 43(4):1229-1240. PubMed ID: 36115903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic Keratopathy After Herpes Zoster Ophthalmicus.
    Meyer JJ; Liu K; McGhee CNJ; Danesh-Meyer HV; Niederer RL
    Cornea; 2022 Nov; 41(11):1433-1436. PubMed ID: 35120347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical cenegermin 0.002% for pediatric neurotrophic keratopathy.
    Elhusseiny AM; Traish AS; Saeed HN; Mantagos IS
    Eur J Ophthalmol; 2022 Nov; 32(6):3420-3424. PubMed ID: 35469461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreoretinopathy-Associated Pediatric Retinal Detachment Treatment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis.
    Belin PJ; Naravane AV; Lu S; Li C; Lum F; Quiram PA
    Ophthalmol Sci; 2023 Sep; 3(3):100273. PubMed ID: 36950302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral corneal perforation caused by neurotrophic keratopathy associated with leprosy: a case report.
    Iraha S; Kondo S; Yamaguchi T; Inoue T
    BMC Ophthalmol; 2022 Jan; 22(1):42. PubMed ID: 35093062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review.
    Ruiz-Lozano RE; Hernandez-Camarena JC; Loya-Garcia D; Merayo-Lloves J; Rodriguez-Garcia A
    Ocul Surf; 2021 Jan; 19():224-240. PubMed ID: 33022412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiscleral Contact Lens Use After Direct Corneal Neurotization for Neurotrophic Keratopathy.
    Morel M; Severinsky B; Kim HJ; Behshad S
    Eye Contact Lens; 2023 Nov; 49(11):471-474. PubMed ID: 37616173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurotrophic keratopathy : Principles, diagnostics and treatment].
    Mergler S; Dietrich-Ntoukas T; Pleyer U
    Ophthalmologe; 2019 Aug; 116(8):797-810. PubMed ID: 31372724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.